SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016169-21-000038
Filing Date
2021-11-04
Accepted
2021-11-04 07:09:07
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atrs-20211104.htm   iXBRL 8-K 38763
2 EX-99.1 atrs-20211104x8kexx991.htm EX-99.1 169934
6 GRAPHIC gbzjl4uq45ct000001a.jpg GRAPHIC 44018
  Complete submission text file 0001016169-21-000038.txt   427704

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrs-20211104.xsd EX-101.SCH 1930
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrs-20211104_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrs-20211104_pre.xml EX-101.PRE 13068
7 EXTRACTED XBRL INSTANCE DOCUMENT atrs-20211104_htm.xml XML 12217
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 211377971
SIC: 3841 Surgical & Medical Instruments & Apparatus